Study on one case of ventrical fibrillation and cardiac arrest during performance of percutaneous transluminal coronary angioplasty (PTCA) and stenting in acute myocardial infarction patient at Central Military Hospital 108. Results: the complication of arrhythmia, ventrical fibrillation and cardiac arrest often occurred in patient with acute inferoposterior wall myocardial infarction. Stent-related complications included embolism, coronary piercing and hemorrhage. All equipment and drugs should be prepared when performing PTCA and stenting, especially patients with arrhythmia must be observed by ICU doctor. Electric defibrillation is the most effective treatment of ventrical fibrillation during PTCA and stenting. If CPR has been done correctly, the patient would fully recover although the time of asystole was more than 10 minutes.
Myocardial Infarction ; Angioplasty, Transluminal, Percutaneous Coronary ; Stents ; Therapeutics ; Heart Arrest

The post cardiac injury syndrome is characterized by the development of a fever, pleuropericarditis, and parenchymal pulmonary infiltrates in the weeks following trauma to the pericardium or myocardium. According to previous reports, almost all cases develop after major cardiac surgery or a myocardial infarction. Recently, a few reports have described post cardiac injury syndrome as a complication of endovascular procedures such as percutaneous cardiac intervention. Here we describe an unusual case of post cardiac injury syndrome after a percutaneous coronary intervention.
Angioplasty, Transluminal, Percutaneous Coronary/*adverse effects ; Heart Diseases/diagnosis/*etiology ; Humans ; Male ; Middle Aged

Based on data comparing coronary-artery bypass grafting (CABG) with medical therapy, the current guidelines recommend CABG as the treatment of choice for patients with left main coronary artery (LMCA) disease. Percutaneous coronary intervention (PCI) can be selectively performed in patients who are candidates for revascularization but who are ineligible for CABG. Current evidence indicates that stenting results in mortality and morbidity rates compared favorably with those seen after CABG. Data from several extensive registries and a large clinical trial may have prompted many interventional cardiologists to choose PCI with stenting as an alternative treatment option for such patients. In addition, these data may inform future guidelines and support the need for well-designed, adequately powered, prospective, randomized trials comparing the two revascularization strategies.
Angioplasty, Transluminal, Percutaneous Coronary/adverse effects/*methods ; Coronary Artery Bypass/*methods ; Coronary Artery Disease/*surgery/*therapy ; Humans ; Stents/adverse effects

No abstract is available.
Angioplasty, Transluminal, Percutaneous Coronary/*adverse effects/methods ; Coronary Disease/diagnosis/*therapy ; Human ; Incidence ; Prognosis ; Recurrence ; Risk Assessment

A 11-year-old girl developed left main coronary artery osteal stenosis after Takayasu's arteritis for which she underwent Percutaneous Transluminal Coronary Angioplasty (PTCA). The narrowing of the left coronary artery was successfully dilated by angioplasty without apparent complication. This one suggests that PTCA may have a potential advantage as a temporary method to postpone the aortocoronary bypass surgery in a child with coronary artery stenosis due to Takayasu's arteritis.
*Angioplasty, Transluminal, Percutaneous Coronary ; Case Report ; Child ; Constriction, Pathologic/etiology/therapy ; Coronary Disease/etiology/*therapy ; Female ; Human ; Takayasu's Arteritis/complications

OBJECTIVES: Initial and late results after implantation of Freedom stents, a balloon expandable stainless steel coil stents were evaluated. METHODS: From Jun. 1996 to Nov. 1997, we implanted 123 Freedom stents in 122 lesions in 117 patients and performed follow-up coronary angiograms at 7.0 3.6 months after stents placement. Clinical courses after stenting and follow-up coronary angiographic findings were evaluated. Comparison of clinical, angiographic, and procedural factors according to the presence or absence of restenosis was performed. RESULTS: In 117 patients who underwent stents implantation, major complications were not observed. Follow-up coronary angiograms were performed in 47 stents in 41 patients (35+ACU-). Among 47 stents, angiographic significant restenosis (percent diameter stenosis +AD4- 50+ACU-) was observed in 13 (28+ACU-). Mean age in 41 patients was 59 9 years, with 27 male patients (66+ACU-). Indications for stents implantation were de novo lesions in 18 (38+ACU-), suboptimal results after PTCA in 18 (38+ACU-), bail-out lesions in 4 (9+ACU-) and restenotic lesions in 7 (15+ACU-). Lesion types by AHA/ACC classification were A in 1 (1+ACU-), B1 in 10 (21+ACU-), B2 in 17 (36+ACU-), and C in 19 (40+ACU-). Average lesion length was 13.7 9.0 mm, stent diameter 3.0 0.3 mm, and stent length 24.6 9.0 mm. There were no significant differences of the clinical, angiographic, and procedural characteristics according to the presence or absence of restenosis. CONCLUSION: Freedom coronary stents implantation is safely performed in various morphology of coronary lesions and no significant predictive factors on restenosis in follow-up coronary angiogram were observed.
Aged ; Angioplasty, Transluminal, Percutaneous Coronary/methods ; Angioplasty, Transluminal, Percutaneous Coronary/instrumentation+ACo- ; Angioplasty, Transluminal, Percutaneous Coronary/adverse effects ; Chi-Square Distribution ; Comparative Study ; Coronary Angiography ; Coronary Disease/therapy+ACo- ; Coronary Disease/radiography ; Female ; Follow-Up Studies ; Human ; Male ; Middle Age ; Predictive Value of Tests ; Probability ; Recurrence ; Stents+ACo-/adverse effects ; Treatment Outcome

OBJECTIVES: To compare the performance of three comorbidity measurements (Charlson comorbidity index, Elixhauser's comorbidity and comorbidity selection) with the effect of different comorbidity lookback periods when predicting in-hospital mortality for patients who underwent percutaneous coronary intervention. METHODS: This was a retrospective study on patients aged 40 years and older who underwent percutaneous coronary intervention. To distinguish comorbidity from complications, the records of diagnosis were drawn from the National Health Insurance Database excluding diagnosis that admitted to the hospital. C-statistic values were used as measures for in comparing the predictability of comorbidity measures with lookback period, and a bootstrapping procedure with 1,000 replications was done to determine approximate 95% confidence interval. RESULTS: Of the 61,815 patients included in this study, the mean age was 63.3 years (standard deviation: +/-10.2) and 64.8% of the population was male. Among them, 1,598 (2.6%) had died in hospital. While the predictive ability of the Elixhauser s comorbidity and comorbidity selection was better than that of the Charlson comorbidity index, there was no significant difference among the three comorbidity measurements. Although the prevalence of comorbidity increased in 3 years of lookback periods, there was no significant improvement compared to 1 year of a lookback period. CONCLUSIONS: In a health outcome study for patients who underwent percutaneous coronary intervention using National Health Insurance Database, the Charlson comorbidity index was easy to apply without significant difference in predictability compared to the other methods. The one year of observation period was adequate to adjust the comorbidity. Further work to select adequate comorbidity measurements and lookback periods on other diseases and procedures are needed.
Adult ; *Angioplasty, Transluminal, Percutaneous Coronary ; *Comorbidity ; Female ; Hospital Mortality ; Humans ; Insurance Claim Review ; Male ; Middle Aged ; Retrospective Studies

Thrombotic thrombocytopenic purpura (TTP) is a rapidly progressive hematological syndrome defined by the pentad of thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, fever and renal dysfunction. TTP has been associated with major surgical procedures and specific medications. However, there is no known previously reported case in which acute TTP occurred after a percutaneous coronary intervention (PCI). We report a case of TTP after a PCI, that presented with the pentad of symptoms, as well as hepatitis and pancreatitis.
Stents/*adverse effects ; Purpura, Thrombotic Thrombocytopenic/diagnosis/*etiology ; Humans ; Female ; Angioplasty, Transluminal, Percutaneous Coronary/*adverse effects ; Aged

Carotid artery stenting has been accepted as a potential alternative to carotid endarterectomy in patients with significant carotid artery stenosis. The objective of this study was to evaluate the feasibility, safety and long-term outcome of percutaneous stenting of carotid artery stenosis in patients with coexisting symptomatic coronary disease. Between May 1996 and May 1999, we performed carotid artery stenting at 48 lesions in 36 patients with carotid stenosis of 60% and symptomatic coronary artery stenosis. Twenty-one patients (58%) had neurologic symptoms. Carotid stenting was performed in 43 internal, 2 external and 3 common carotid lesions. We used Wallstent in 46 lesions, Palmaz stent in 2 lesions and Microstent II in 1 lesion. Staged or combined coronary intervention was performed in 18 patients (50%) and staged coronary artery bypass surgery was performed in 6 patients (17%). In the other 12 patients (33%), medical treatments were performed. Carotid stenting was successful in all lesions. Simultaneous bilateral carotid stenting was performed in 11 patients (31%). One major and 1 minor stroke developed during the procedure. There were no deaths during the procedures and within 30 days post-procedure. During the follow-up of 14 +/- 7 (3 to 40) months, there were no deaths or neurological events. On follow-up (6 +/- 1 months) angiography and/or duplex sonography of 44 eligible lesions in 32 patients, there were 2 cases of asymptomatic restenosis (4.5%) which developed in Palmaz stents implanted at the external carotid artery and the common carotid artery, respectively. In conclusion, carotid artery stenting in patients with coexistent carotid and coronary artery disease is feasible, safe and shows favorable follow-up outcomes.
Aged ; Angioplasty, Transluminal, Percutaneous Coronary* ; Carotid Arteries* ; Coronary Angiography ; Coronary Disease/therapy* ; Coronary Disease/radiography ; Female ; Follow-Up Studies ; Human ; Male ; Middle Age ; Postoperative Complications ; Stents*

Insulin resistance is an important risk factor for coronary artery disease. However, there has been no data regarding its clinical effect on the outcomes of percutaneous coronary intervention (PCI) in non-diabetic patients. We analyzed 98 non-diabetic consecutive patients (59+/-11.5 yr, male:female=63:35) who underwent elective coronary angiography. The patients were divided into two groups: Group I (n=71; the value of HOMA-IR [homeostasis model assessment of insulin resistance] <2.6) and Group II (n=27; the value of HOMA-IR > or = 2.6). In-hospital and 30-day major adverse cardiac events (MACE) were compared between the two groups. The concentrations of fasting insulin and triglyceride were significantly higher in Group II than in Group I. Significant correlations were observed between the value of HOMA-IR and body mass index (r=0.489, p<0.001), levels of total cholesterol (r=0.204, p=0.045), triglyceride (r=0.334, p=0.001) and apolipoprotein B (r=0.212, p=0.038). PCI was performed in 59 patients (60.2%). In-hospital and 30-day MACE were higher in Group II than Group I (2.4% vs. 27.8%, p=0.008; 2.4% vs. 27.8%, p=0.008). Multivariate analysis revealed that the value of HOMA-IR > or = 2.6 was an independent predictor of MACE. Increased HOMA-IR level is an important prognostic indicator in non-diabetic patients underwent PCI.
Prognosis ; Models, Biological ; Middle Aged ; Male ; *Insulin Resistance ; Humans ; Homeostasis ; Female ; Coronary Stenosis/blood/physiopathology/therapy ; Coronary Arteriosclerosis/blood/physiopathology/therapy ; *Angioplasty, Transluminal, Percutaneous Coronary/adverse effects ; Aged